Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-314
Closed -$31.7K 902
2023
Q3
$31.7K Hold
314
0.01% 556
2023
Q2
$42.7K Sell
314
-78
-20% -$9.52K 0.01% 518
2023
Q1
$40.7K Hold
392
0.01% 515
2022
Q4
$35K Buy
+392
New +$32.5K 0.01% 533

Other funds holding CNMD

Park Place Capital's CNMD Position: Q4 2023 in Review

Park Place Capital sold out of CONMED (CNMD) in Q4 2023, closing a stake of 314 shares — an estimated $31.7K sold.

Park Place Capital first reported a position in CNMD in Q4 2022 and held it in 4 quarters. The position peaked at $42.7K in Q2 2023. 306 funds tracked by Wall St. Rank hold CNMD as of Q4 2023.

  • Park Place Capital reported no remaining CONMED position as of Q4 2023 after selling out during the quarter.
  • Park Place Capital sold 314 CONMED shares in Q4 2023, an estimated $31.7K.
  • Park Place Capital first reported a position in CONMED in Q4 2022 and held it in 4 quarters.
  • Park Place Capital's CONMED position peaked at $42.7K in Q2 2023.
  • 306 funds tracked by Wall St. Rank held CONMED as of Q4 2023.

Based on Park Place Capital's 13F filing for Q4 2023, filed 24 Jan 2024.